Prevalence and Correlates of Cervical Cancer Screening Among Injection Drug Users

Journal of Obstetrics and Gynaecology Canada

Volumn 28, Issue 8, 2006, Pages 695-699

  McKnight, Bruce ^a   McKnight, Ian ^a   Kerr, Thomas ^a,b   Li, Kathy ^a   Montaner, Julio ^a,b   Wood, Evan ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Access to health care; Cervical cancer; Injection drug use

Indexed keywords

METHADONE;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER SCREENING; COCAINE DEPENDENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HEPATITIS C; HEROIN DEPENDENCE; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PREVALENCE; PROSTITUTION; SMOKING; UTERINE CERVIX CANCER; AGE; ANALYSIS OF VARIANCE; CANADA; COHORT ANALYSIS; CONFIDENCE INTERVAL; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDY; RISK; RISK FACTOR; STATISTICAL MODEL; STATISTICS; SUBSTANCE ABUSE; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; BRITISH COLUMBIA; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MASS SCREENING; MIDDLE AGED; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 39049192012     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)32237-X     Document Type: Article

References (19)

1. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 2006, 56(2):106-130.
2. Hoffman M.S., Cavanagh D. Cervical cancer: screening and prevention of invasive disease. Cancer Control 1995, 2(6):503-509.
3. Morantz C. ACS guidelines for early detection of cancer. Am Fam Physician 2004, 69(8):2013.
4. Bundrick J.B., Cook D.A., Gostout B.S. Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing. Mayo Clin Proc 2005, 80(8):1063-1068.
5. Wright T.C., Cox J.T., Massad L.S., Carlson J., Twiggs L.B., Wilkinson E.J. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2003, 189(l):295-304.
6. Spitzer M., Apgar B.S., Brotzman G.L. Management of histologic abnormalities of the cervix. Am Fam Physician 2006, 73(1):105-112.
7. Eddy D.M. Screening for cervical cancer. Ann Intern Med 1990, 113(3):214-226.
8. Wong J.G., Feussner J.R. Screening for cervical cancer. Pap smears can save lives. N C Med J 1993, 54(7):342-345.
9. Segnan N. Socioeconomic status and cancer screening. IARC Sci Publ 1997, 138:369-376.
10. Reynolds D. Cervical cancer in Hispanic/Latino women. Clin J Oncol Nurs 2004, 8(2):146-150.
11. Behbakht K., Lynch A., Teal S., Degeest K., Massad S. Social and cultural barriers to Papanicolaou test screening in an urban population. Obstet Gynecol 2004, 104(6):1355-1361.
12. Hawes S.E., Critchlow C.W., Sow P.S., Toure P., N'Doye I., Diop A., et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst 2006, 98(2):100-109.
13. Wiley D.J., Monk B.J., Masongsong E., Morgan K. Cervical cancer screening. Curr Oncol Rep 2004, 6(6):497-506.
14. Strathdee S.A., Patrick D.M., Currie S.L., Cornelisse P.G., Rekart M.L., Montaner J.S., et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997, 11(8):F59-F65.
15. Wood E., Hogg R.S., Bonner S., Kerr T., Li K., Palepu A., et al. Staging for antiretroviral therapy among HIV-infected drug users. JAMA 2004, 292(10):1175-1177.
16. Kerr T., Tyndall M., Li K., Montaner J.S., Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005, 366(9482):316-318.
17. Wood E., Hogg R.S., Kerr T., Palepu A., Zhang R., Montaner J.S. Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users. Aids 2005, 19(8):837-839.
18. Wood E., Kerr T., Montaner J.S., Strathdee S.A., Wodak A., Hankins C.A., et al. Rationale for evaluating North America's first medically supervised safer injecting facility. Lancet Infect Dis 2004, 4:301-306.
19. Des Jarlais D.C., Paone D., Milliken J., Turner C.F., Miller H., Gribble J., et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. Lancet 1999, 353(9165):1657-1661.